NGL Fine-Chem Limited Total Liabilities
NGL Fine-Chem Limited total liabilities. Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has total liabilities worth Rs2.16 Billion INR (≈ $23.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of NGL Fine-Chem Limited to evaluate the company's liquid asset resilience ratio.
Total Liabilities of NGL Fine-Chem Limited (2009–2026)
Total liabilities of NGL Fine-Chem Limited from 2009 to 2026. This chart illustrates how NGL Fine-Chem Limited's total liabilities have evolved over time, based on quarterly financial data.
NGL Fine-Chem Limited Competitors by Total Liabilities
The table below lists competitors of NGL Fine-Chem Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Quercus TFI SA
WAR:QRS
|
Poland | zł143.83 Million |
|
Iron Force Industrial Co Ltd
TW:2228
|
Taiwan | NT$1.98 Billion |
|
Shandong Longertek Technology Co Ltd
SHE:300594
|
China | CN¥1.09 Billion |
|
Bursa De Valori Bucuresti SA
RO:BVB
|
Romania | RON64.32 Million |
|
Hinduja Global Solutions Limited
NSE:HGS
|
India | Rs31.28 Billion |
|
Autosports Group Ltd
AU:ASG
|
Australia | AU$1.53 Billion |
|
Icelandic Salmon As
OL:ISLAX
|
Norway | Nkr153.36 Million |
|
Count Ltd
AU:CUP
|
Australia | AU$322.99 Million |
Liability Composition Analysis (2009–2026)
This chart breaks down NGL Fine-Chem Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NGL Fine-Chem Limited balance sheet assets.
Liquidity & Leverage Metrics
NGL Fine-Chem Limited Total Liabilities Ratios Explained
NGL Fine-Chem Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NGL Fine-Chem Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NGL Fine-Chem Limited (2009–2026)
The table below shows the annual total liabilities of NGL Fine-Chem Limited from 2009 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs2.16 Billion ≈ $23.39 Million |
+43.26% |
| 2025-03-31 | Rs1.51 Billion ≈ $16.33 Million |
+62.49% |
| 2024-03-31 | Rs929.04 Million ≈ $10.05 Million |
+43.97% |
| 2023-03-31 | Rs645.30 Million ≈ $6.98 Million |
-12.45% |
| 2022-03-31 | Rs737.10 Million ≈ $7.97 Million |
+38.27% |
| 2021-03-31 | Rs533.08 Million ≈ $5.77 Million |
-2.47% |
| 2020-03-31 | Rs546.60 Million ≈ $5.91 Million |
+9.17% |
| 2019-03-31 | Rs500.68 Million ≈ $5.41 Million |
-12.54% |
| 2018-03-31 | Rs572.49 Million ≈ $6.19 Million |
+33.95% |
| 2017-03-31 | Rs427.38 Million ≈ $4.62 Million |
+28.37% |
| 2016-03-31 | Rs332.92 Million ≈ $3.60 Million |
-1.21% |
| 2015-03-31 | Rs337.01 Million ≈ $3.64 Million |
+7.66% |
| 2014-03-31 | Rs313.02 Million ≈ $3.39 Million |
+14.32% |
| 2013-03-31 | Rs273.81 Million ≈ $2.96 Million |
+36.33% |
| 2012-03-31 | Rs200.84 Million ≈ $2.17 Million |
+19.59% |
| 2011-03-31 | Rs167.94 Million ≈ $1.82 Million |
+43.35% |
| 2010-03-31 | Rs117.15 Million ≈ $1.27 Million |
+24.34% |
| 2009-03-31 | Rs94.22 Million ≈ $1.02 Million |
-- |
About NGL Fine-Chem Limited
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosph… Read more